April 20, 2023

Comprehensive STEMI Protocol Equitably Improves Key Care Process Metrics

Black and white patients realize similar gains following adoption of new protocol

patient on gurney being rushed to emergency ward

Implementation of a comprehensive protocol for management of ST-elevation myocardial infarction (STEMI) similarly benefits Black and white patients, suggesting that widespread protocol adoption could help reduce traditional racial disparities in STEMI care delivery. So found a study that compared STEMI care metrics between these two groups before and up to five years after Cleveland Clinic adopted a comprehensive STEMI protocol. The study was published online in the Journal of the American Heart Association.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“This is the first study to show that a comprehensive STEMI protocol can successfully and equitably improve care for Black and white American patients,” says Umesh Khot, MD, Head of Regional Cardiovascular Medicine at Cleveland Clinic and corresponding author of the study. “Rapid identification of STEMI, development of standardized care protocols and procedural optimization were key components of the protocol, which yielded outcome gains across the board.”

A backdrop of racial disparities in healthcare

It is well recognized that Black Americans with STEMI tend to receive poorer care compared with white Americans, with studies documenting transfer delays, lower rates of revascularization and longer door-to-balloon times. Such differences are believed to contribute to poorer STEMI outcomes among Black patients.

In July 2014, Cleveland Clinic implemented a comprehensive STEMI protocol designed to standardize care to improve process metrics and clinical outcomes among all patients.

Protocol in brief

The comprehensive STEMI protocol included the following major elements:

  • Standard criteria by which emergency department physicians can activate the catheterization lab
  • Use of a “STEMI safe handoff checklist,” which defined roles of all involved caregivers
  • Immediate transfer to a catheterization lab
  • Use of a “radial artery first” approach for vascular access in primary percutaneous coronary intervention (PCI) for suitable candidates

Study design and findings

The study retrospectively examined medical records from consecutive patients with STEMI treated with PCI at Cleveland Clinic’s main campus, comparing those treated before the comprehensive STEMI protocol was adopted (January 1, 2011, to July 14, 2014) with those treated after protocol adoption (July 15, 2014, to July 15, 2019). The cohorts’ racial makeup was as follows:

Advertisement
  • Pre-protocol: 208 Black patients and 479 white patients
  • Post-protocol: 271 Black patients and 793 white patients

Patients from other racial groups made up less than 1% of the identified population and were excluded.

Pre- and post-protocol cohorts were similar in age, sex and comorbidities, although fewer patients had a prior myocardial infarction in both post-protocol cohorts, and body mass index among white patients was higher in the post-protocol cohort.

Protocol adoption resulted in the following changes in key metrics among Black patients:

  • Administration of guideline-directed medical therapy prior to PCI increased from 71.6% pre-protocol to 81.9% post-protocol (P = 0.01).
  • Use of radial PCI increased from 14.4% to 73.8% (P < 0.001).
  • Median door-to-balloon time decreased from 90 to 70 minutes (P < 0.001).
  • Median fluoroscopy dose decreased from 1,610 to 1,147 mGy (P < 0.001).
  • Median contrast dose decreased from 180 to 145 mL (P < 0.001).

Regression models developed for each key process metric revealed no significant interaction with race. “Race was not found to be a factor in the benefits achieved after adopting the comprehensive STEMI protocol,” observes study co-author Grant Reed, MD, MSc, Quality Improvement Officer in Cleveland Clinic’s Section of Invasive and Interventional Cardiology. “This indicates that gains from the protocol were equitable between Black and white patients.”

A protocol with multiple benefits

Previous analyses of the effects of the adoption of Cleveland Clinic’s comprehensive STEMI protocol found that it also achieved benefits among other traditionally underserved groups. One study, published in the European Heart Journal Open and summarized in a Consult QD post, found that gains in key process metrics were made for men and women, eliminating the gender gap in most process and outcome metrics (table).

Advertisement

Another study (table) found that adoption of the comprehensive STEMI protocol reduced socioeconomic disparities not only in care process metrics but in clinical outcomes, most notably in-hospital mortality (complete study published in the Journal of the American Heart Association and summarized here).

“These diverse studies on a single new approach to STEMI care indicate that standardizing healthcare delivery can benefit everyone, including traditionally underserved populations,” Dr. Khot concludes. “Establishing and adopting a comprehensive STEMI protocol like ours should be a major priority of hospital systems, especially those that serve large Black or socioeconomically disadvantaged populations. It’s encouraging that a single approach has been shown to reduce or eliminate disparities on three fronts — race, socioeconomic status and gender.”

Related Articles

angiograms of a percutaneous coronary intervention
December 22, 2023
Registry Study Shows Growth in Use of Carlino Technique for High-Complexity CTOs

While procedural success rates lag overall, they shine for retrograde crossing

23-HVI-4298710_LAAO+TAVR_650x450
October 24, 2023
Concurrent TAVR and Watchman Placement Is Noninferior to TAVR Plus Medical Therapy for Atrial Fibrillation

Randomized WATCH-TAVR trial confirms safety of the combined procedures

23-HVI-4078311_chronic-total-occlusion_650x450
August 21, 2023
Study Links Distal Target Vessel Quality With PCI Outcomes in Chronic Total Occlusion

Lower success rates, more hospital MACE seen with poor-quality distal targets

22-HVI-3435931_cath-lab_650x450
January 18, 2023
Simple Measures for Cath Lab Radiation Dose Reduction Significantly Lower Exposure

Cleveland Clinic experience is applicable to other laboratories

22-HVI-3221311 CQD 650&#215;450
September 22, 2022
PROTECTED TAVR Finds Reduced Rate of Disabling Stroke With Cerebral Embolic Protection

Results from largest randomized trial of the technology to date

21-HVI-2340465-Hero-650&#215;450
July 1, 2022
Coronary Sinus Reducing Device: A New Option for Refractory Angina May Soon Be at Hand

Pivotal COSIRA-II multicenter U.S. clinical trial is underway

22-HVI-2918751 TAVR_650x450
May 9, 2022
Same-Day Discharge After Transfemoral TAVR Is Feasible and Safe in Appropriate Patients

Protocol promises to shape patient satisfaction, hospital resource utilization

22-HVI-2623150 CQD 650&#215;450
February 28, 2022
INOCA: A Common, Dangerous, Often Overlooked Cause of Chest Pain

What to do when a patient’s ischemia is not due to coronary artery stenosis

Ad